InvestingThe Economic Times Reports Sun Pharma Above Its 20-day AverageBy Celia RowanOct 30, 2026, 4:15 AM UTC
HealthSun Pharma to Present Long-Term UNLOXCYT Data at ESMO After 205-Patient Study UpdateBy Naomi CalderOct 23, 2026, 11:15 PM UTC
EconomySun Pharma Accepts ₹78.16 Billion in Bond Bids, Below ₹100 Billion GoalBy Adrian ValeOct 23, 2026, 12:31 PM UTC
InvestingSun Pharma Shares Recover From Intraday Dip Before Oct. 30 ResultsBy Celia RowanOct 21, 2026, 1:16 PM UTC
BusinessSun Pharma Board Authorizes Up to ₹10,000 Crore in BondsBy Helena WardOct 21, 2026, 9:46 AM UTC
InvestingOrchid Pharma Board Approves Exploring a Raise of Up to Rs 600 CroreBy Celia RowanOct 21, 2026, 9:01 AM UTC
HealthSkin Cancer Guidelines Add UNLOXCYT as Category 2A Option, Sun Pharma SaysBy Naomi CalderOct 21, 2026, 1:20 AM UTC
InvestingSun Pharma Shares Close 0.15% Lower Before Oct. 30 ResultsBy Celia RowanOct 19, 2026, 5:44 AM UTC
